Profile data is unavailable for this security.
About the company
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.
- Revenue in JPY (TTM)891.41bn
- Net income in JPY121.91bn
- Incorporated1919
- Employees31.56k
- LocationOlympus CorpShinjuku Monolith, 2-3-1, Nishi-ShinjukuSHINJUKU-KU 163-0914JapanJPN
- Phone+81 333402111
- Fax+81 333402062
- Websitehttps://www.olympus.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| iRay Technology Co Ltd | 27.47bn | 11.19bn | 742.71bn | 788.00 | 66.42 | 11.44 | -- | 27.04 | 7.59 | 7.59 | 18.63 | 44.06 | 0.3812 | 1.51 | 5.09 | 1,716,121.00 | 15.52 | -- | 17.65 | -- | 56.90 | -- | 40.71 | -- | 5.25 | -- | 0.0821 | -- | 51.43 | -- | 117.79 | -- | -- | -- |
| Shandong Weigao Group Medical Polymer Co | 281.85bn | 50.59bn | 799.53bn | 11.48k | 15.62 | 1.91 | 11.28 | 2.84 | 0.6083 | 0.6083 | 3.39 | 4.97 | 0.4443 | 3.79 | 2.60 | 1,376,146.00 | 8.69 | 7.94 | 11.38 | 9.79 | 51.38 | 59.02 | 19.56 | 18.66 | 2.67 | 43.69 | 0.1668 | 29.53 | 13.16 | 18.54 | 7.57 | 17.53 | 12.45 | 10.10 |
| Fisher & Paykel Healthcare Corp Ltd | 139.12bn | 31.18bn | 912.49bn | 7.38k | 29.39 | 6.56 | 24.03 | 6.56 | 0.6499 | 0.6499 | 2.90 | 2.91 | 0.8043 | 2.00 | 8.47 | 228,027.10 | 18.02 | 21.95 | 21.85 | 26.98 | 62.60 | 64.59 | 22.41 | 22.79 | 1.74 | 361.14 | 0.0585 | 47.97 | -14.69 | 13.46 | -28.10 | 17.38 | 21.94 | 15.16 |
| Cochlear Limited | 155.27bn | 27.23bn | 1.25tn | 4.50k | 46.03 | 7.90 | 36.34 | 8.07 | 4.40 | 4.40 | 25.06 | 25.63 | 0.674 | 1.64 | 5.11 | 366,288.90 | 11.82 | 9.70 | 14.60 | 12.88 | 75.86 | 74.70 | 17.54 | 12.49 | 2.00 | -- | 0.1309 | 90.63 | 10.06 | 5.62 | -11.45 | 5.27 | 1.67 | -1.25 |
| Terumo Corp | 728.93bn | 83.32bn | 3.12tn | 28.29k | 37.36 | 2.79 | 21.56 | 4.28 | 110.08 | 110.08 | 962.98 | 1,476.15 | 0.4988 | 1.77 | 5.43 | 25,762,560.00 | 5.70 | 6.98 | 6.52 | 8.29 | 51.68 | 53.80 | 11.43 | 13.45 | 2.03 | 54.97 | 0.1742 | 25.19 | 14.57 | 6.47 | 14.94 | 10.06 | 13.93 | 10.12 |
| FUJIFILM Holdings Corp | 2.57tn | 195.22bn | 3.37tn | 75.47k | 13.45 | 0.987 | 10.36 | 1.31 | 486.37 | 486.37 | 6,400.39 | 6,628.15 | 0.653 | 2.92 | 4.92 | 34,037,950.00 | 4.78 | 4.68 | 6.15 | 6.15 | 40.29 | 40.54 | 7.32 | 6.90 | 1.31 | 423.02 | 0.1755 | 23.67 | 15.20 | 1.70 | 16.54 | 9.94 | 11.34 | 9.46 |
| Olympus Corp | 891.41bn | 121.91bn | 3.60tn | 31.56k | 29.42 | 6.13 | 19.08 | 4.04 | 95.15 | 95.15 | 696.15 | 456.48 | 0.6915 | 1.74 | 5.55 | 28,247,620.00 | 9.48 | 5.83 | 12.65 | 8.36 | 65.69 | 64.40 | 13.70 | 7.81 | 1.48 | 38.28 | 0.4041 | 21.46 | 18.93 | 3.25 | 76.44 | 22.02 | 0.5139 | 14.87 |
Data as of Oct 04 2022. Currency figures normalised to Olympus Corp's reporting currency: Japanese Yen JPY
31.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 Aug 2022 | 76.08m | 5.92% |
| Baillie Gifford & Co.as of 30 Jun 2021 | 65.60m | 5.10% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2022 | 56.37m | 4.38% |
| Nikko Asset Management Co., Ltd.as of 15 Jun 2021 | 42.08m | 3.27% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Jun 2021 | 37.31m | 2.90% |
| Daiwa Asset Management Co. Ltd.as of 31 Aug 2022 | 34.77m | 2.70% |
| The Vanguard Group, Inc.as of 09 Sep 2022 | 32.69m | 2.54% |
| BlackRock Fund Advisorsas of 08 Sep 2022 | 21.15m | 1.65% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 28 Mar 2022 | 19.91m | 1.55% |
| Capital International Ltd.as of 08 Sep 2022 | 18.94m | 1.47% |
More ▼
Data from 16 May 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
